Product How it works Pricing Blog FAQ About Contact
Monopar Therapeutics

Monopar Therapeutics (NASDAQ: MNPR) revenue

Monopar Therapeutics reported revenue of $0.0m for fiscal 2025; in fiscal 2024 it was $0.0m.

Fiscal 2025 is the highest of the 6 fiscal years on record for Monopar Therapeutics.

Revenue, in millions of US dollars0.020160.020170.020180.020190.020240.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$0.0m—−$16.7m—
2024$0.0m—−$16.2m—
2019$0.0m—−$4.3m—
2018$0.0m—−$3.3m—
2017$0.0m—−$16.6m—
2016$0.0m—−$1.2m—

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Monopar Therapeutics revenue compared with its sector

By revenue for its latest fiscal year, Monopar Therapeutics ranks 410th of the 422 US health care companies with a page on Celsmar.

RankCompanyRevenueRevenue growth
408thDesign Therapeutics$0.0m—
409thFulcrum Therapeutics$0.0m−100.0%
410thMonopar Therapeutics$0.0m—
411thNeurogene$0.0m−100.0%
412thNkarta$0.0m—

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Monopar Therapeutics

How much revenue did Monopar Therapeutics make in fiscal 2025?
Monopar Therapeutics reported revenue of $0.0m for fiscal 2025, compared with $0.0m in fiscal 2024.
What was the best year for revenue at Monopar Therapeutics?
Of its last 6 fiscal years, fiscal 2025, with $0.0m.
Where does Monopar Therapeutics rank in its sector by revenue?
It ranks 410th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Monopar Therapeutics come from?
From the annual report (Form 10-K) that Monopar Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Monopar Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2019 · 2018 · 2017 · 2016. More on Monopar Therapeutics: the Monopar Therapeutics page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.